BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 26411502)

  • 1. Adaptive deep brain stimulation in Parkinson's disease.
    Beudel M; Brown P
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(Suppl 1):S123-6. PubMed ID: 26411502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute effects of adaptive Deep Brain Stimulation in Parkinson's disease.
    Piña-Fuentes D; van Dijk JMC; van Zijl JC; Moes HR; van Laar T; Oterdoom DLM; Little S; Brown P; Beudel M
    Brain Stimul; 2020; 13(6):1507-1516. PubMed ID: 32738409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-triggered adaptive deep brain stimulation during reaching movement in Parkinson's disease.
    He S; Baig F; Merla A; Torrecillos F; Perera A; Wiest C; Debarros J; Benjaber M; Hart MG; Ricciardi L; Morgante F; Hasegawa H; Samuel M; Edwards M; Denison T; Pogosyan A; Ashkan K; Pereira E; Tan H
    Brain; 2023 Dec; 146(12):5015-5030. PubMed ID: 37433037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Motion sensor strategies for automated optimization of deep brain stimulation in Parkinson's disease.
    Pulliam CL; Heldman DA; Orcutt TH; Mera TO; Giuffrida JP; Vitek JL
    Parkinsonism Relat Disord; 2015 Apr; 21(4):378-82. PubMed ID: 25703990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic review of local field potential physiomarkers in Parkinson's disease: from clinical correlations to adaptive deep brain stimulation algorithms.
    van Wijk BCM; de Bie RMA; Beudel M
    J Neurol; 2023 Feb; 270(2):1162-1177. PubMed ID: 36209243
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive deep brain stimulation (aDBS) controlled by local field potential oscillations.
    Priori A; Foffani G; Rossi L; Marceglia S
    Exp Neurol; 2013 Jul; 245():77-86. PubMed ID: 23022916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effective subthalamic nucleus deep brain stimulation sites may differ for tremor, bradykinesia and gait disturbances in Parkinson's disease.
    Hilliard JD; Frysinger RC; Elias WJ
    Stereotact Funct Neurosurg; 2011; 89(6):357-64. PubMed ID: 22104373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stimulation of the caudal zona incerta is superior to stimulation of the subthalamic nucleus in improving contralateral parkinsonism.
    Plaha P; Ben-Shlomo Y; Patel NK; Gill SS
    Brain; 2006 Jul; 129(Pt 7):1732-47. PubMed ID: 16720681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What brain signals are suitable for feedback control of deep brain stimulation in Parkinson's disease?
    Little S; Brown P
    Ann N Y Acad Sci; 2012 Aug; 1265(1):9-24. PubMed ID: 22830645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unilateral caudal zona incerta deep brain stimulation for Parkinsonian tremor.
    Blomstedt P; Fytagoridis A; Åström M; Linder J; Forsgren L; Hariz MI
    Parkinsonism Relat Disord; 2012 Dec; 18(10):1062-6. PubMed ID: 22709794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in intracortical inhibition and clinical symptoms after STN-DBS in Parkinson's disease.
    Kobayashi M; Ohira T; Mihara B; Fujimaki T
    Clin Neurophysiol; 2016 Apr; 127(4):2031-7. PubMed ID: 26971486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Two-year follow-up on the effect of unilateral subthalamic deep brain stimulation in highly asymmetric Parkinson's disease.
    Kim HJ; Paek SH; Kim JY; Lee JY; Lim YH; Kim DG; Jeon BS
    Mov Disord; 2009 Feb; 24(3):329-35. PubMed ID: 19006187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving outcomes of subthalamic nucleus deep brain stimulation in Parkinson's disease.
    Bari AA; Fasano A; Munhoz RP; Lozano AM
    Expert Rev Neurother; 2015 Oct; 15(10):1151-60. PubMed ID: 26377740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local field potential beta activity in the subthalamic nucleus of patients with Parkinson's disease is associated with improvements in bradykinesia after dopamine and deep brain stimulation.
    Ray NJ; Jenkinson N; Wang S; Holland P; Brittain JS; Joint C; Stein JF; Aziz T
    Exp Neurol; 2008 Sep; 213(1):108-13. PubMed ID: 18619592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease.
    Anderson VC; Burchiel KJ; Hogarth P; Favre J; Hammerstad JP
    Arch Neurol; 2005 Apr; 62(4):554-60. PubMed ID: 15824252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of deep brain stimulation and medication on strength, bradykinesia, and electromyographic patterns of the ankle joint in Parkinson's disease.
    Vaillancourt DE; Prodoehl J; Sturman MM; Bakay RA; Metman LV; Corcos DM
    Mov Disord; 2006 Jan; 21(1):50-8. PubMed ID: 16124011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual threshold neural closed loop deep brain stimulation in Parkinson disease patients.
    Velisar A; Syrkin-Nikolau J; Blumenfeld Z; Trager MH; Afzal MF; Prabhakar V; Bronte-Stewart H
    Brain Stimul; 2019; 12(4):868-876. PubMed ID: 30833216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adaptive deep brain stimulation: Retuning Parkinson's disease.
    Pozzi NG; Isaias IU
    Handb Clin Neurol; 2022; 184():273-284. PubMed ID: 35034741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adaptive Brain Stimulation for Movement Disorders.
    Beudel M; Cagnan H; Little S
    Prog Neurol Surg; 2018; 33():230-242. PubMed ID: 29332087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease and pathological oscillatory activity: is the beta band the bad guy? - New lessons learned from low-frequency deep brain stimulation.
    Timmermann L; Florin E
    Exp Neurol; 2012 Jan; 233(1):123-5. PubMed ID: 22075181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.